Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 568
5
Diseases
3
Unique genes
0.357
Avg. similarity score
Auditory neuropathy with optic atrophy
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Auditory neuropathy with optic atrophy
Multiple mitochondrial dysfunctions syndrome 9b
Optic atrophy mitochondrial dysfunction syndrome
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
Autosomal recessive optic atrophy, OPA7 type
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Auditory neuropathy with optic atrophy | 4 | 4 | 3 |
| Multiple mitochondrial dysfunctions syndrome 9b | 3 | 3 | 1 |
| Optic atrophy mitochondrial dysfunction syndrome | 3 | 3 | 1 |
| Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome | 3 | 3 | 1 |
| Autosomal recessive optic atrophy, OPA7 type | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FDXR | 4 / 5 | Auditory neuropathy with optic atrophy, Multiple mitochondrial dysfunctions syndrome 9b, Optic atrophy mitochondrial dysfunction syndrome, Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome |
| TMEM126A | 2 / 5 | Auditory neuropathy with optic atrophy, Autosomal recessive optic atrophy, OPA7 type |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Electron transport from NADPH to Ferredoxin | Reactome | 1 / 3 | 1,334× | 7.49e-4 | 9.09e-3 ✓ sig. |
| Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) | Reactome | 1 / 4 | 1,001× | 9.99e-4 | 1.13e-2 ✓ sig. |
| Assembly and cell surface presentation of NMDA receptors | Reactome | 1 / 6 | 667× | 1.50e-3 | 1.54e-2 ✓ sig. |
| Pregnenolone biosynthesis | Reactome | 1 / 12 | 334× | 2.99e-3 | 2.54e-2 ✓ sig. |
| Synaptic adhesion-like molecules | Reactome | 1 / 21 | 191× | 5.24e-3 | 3.76e-2 ✓ sig. |
| Unblocking of NMDA receptors, glutamate binding and activation | Reactome | 1 / 22 | 182× | 5.49e-3 | 3.87e-2 ✓ sig. |
| Endogenous sterols | Reactome | 1 / 25 | 160× | 6.23e-3 | 4.21e-2 ✓ sig. |
| Nicotine addiction | KEGG | 1 / 41 | 97.6× | 1.02e-2 | 5.76e-2 |
| Cocaine addiction | KEGG | 1 / 49 | 81.7× | 1.22e-2 | 6.42e-2 |
| Long-term potentiation | KEGG | 1 / 67 | 59.8× | 1.66e-2 | 7.70e-2 |
| Amphetamine addiction | KEGG | 1 / 69 | 58.0× | 1.71e-2 | 7.85e-2 |
| Circadian entrainment | KEGG | 1 / 97 | 41.3× | 2.40e-2 | 9.53e-2 |
| Glutamatergic synapse | KEGG | 1 / 116 | 34.5× | 2.87e-2 | 1.06e-1 |
| Spinocerebellar ataxia | KEGG | 1 / 144 | 27.8× | 3.55e-2 | 1.19e-1 |
| Alcoholism | KEGG | 1 / 188 | 21.3× | 4.62e-2 | 1.38e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| directional locomotion | GO:0033058 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| protein localization to postsynaptic membrane | GO:1903539 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| mitochondrial protein quality control | GO:0141164 | 1 / 4 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| protein insertion into mitochondrial inner membrane from matrix | GO:0032979 | 1 / 5 | 1,246× | 8.03e-4 | 1.28e-2 ✓ sig. |
| calcium ion transmembrane import into cytosol | GO:0097553 | 1 / 10 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| regulation of monoatomic cation transmembrane transport | GO:1904062 | 1 / 10 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| excitatory chemical synaptic transmission | GO:0098976 | 1 / 13 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |
| optic nerve development | GO:0021554 | 1 / 15 | 415× | 2.41e-3 | 2.32e-2 ✓ sig. |
| ubiquinone biosynthetic process | GO:0006744 | 1 / 17 | 366× | 2.73e-3 | 2.48e-2 ✓ sig. |
| glutamate receptor signaling pathway | GO:0007215 | 1 / 19 | 328× | 3.05e-3 | 2.62e-2 ✓ sig. |
| ionotropic glutamate receptor signaling pathway | GO:0035235 | 1 / 23 | 271× | 3.69e-3 | 2.89e-2 ✓ sig. |
| regulation of neuronal synaptic plasticity | GO:0048168 | 1 / 26 | 240× | 4.17e-3 | 3.06e-2 ✓ sig. |
| positive regulation of synaptic transmission, glutamatergic | GO:0051968 | 1 / 28 | 222× | 4.49e-3 | 3.17e-2 ✓ sig. |
| positive regulation of excitatory postsynaptic potential | GO:2000463 | 1 / 32 | 195× | 5.13e-3 | 3.37e-2 ✓ sig. |
| mitochondrial respiratory chain complex I assembly | GO:0032981 | 1 / 40 | 156× | 6.41e-3 | 3.73e-2 ✓ sig. |